Ask Our Experts July 10, 2023 Summer skin protection checklist While our skin needs protection from the sun throughout the year, the increased time spent in the sun during the summer can raise the risk of skin damage and skin cancer. Here is PHM’s recommended checklist on the best ways to protect yourself from the sun’s damaging UV rays and reduce your risk of developing skin cancer. Read More
Ask Our Experts July 10, 2023 Treating hot flashes without hormones Hot flashes are the most common symptom of menopause, occurring in 75% of all women and often persisting for years. For some women, hot flashes are mild, infrequent, and do not require treatment. Others have more intense and frequent hot flashes that negatively affect their quality of life, including sleep interruption, mood changes, difficulty concentrating, and interference with daily activities. Read now for a brief review the existing treatments and a newly approved, non-hormonal treatment option. Read More
Case Studies June 1, 2023 Changing the narrative of a cancer journey Battling cancer once is extremely scary and difficult, and Carrie’s first battle was no exception. When she was diagnosed with cancer a second time, her husband sought help from PHM, an employer provided benefit. With PHM, the narrative of Carrie's cancer journey changed for the better. Read More
Ask Our Experts May 26, 2023 New frontiers in breast cancer management For a very long time, the only option for breast cancer treatment was a radical mastectomy. Treatment slowly began to evolve in the 1960s with hormone therapy, radiation, and chemotherapy being adopted into clinical practice. But today, treatment options are evolving much more rapidly. Read More
Published Research May 10, 2023 Innovative treatment for prostate cancer shows long-term success Prostate cancer is the second most common cancer in men and the fifth leading cause of cancer death worldwide. Despite decades of research and multiple treatment options including chemo and hormone therapies, many patients still experience worsening disease and develop metastatic castration-resistant prostate cancer (mCRPC), which is typically fatal. Providing these patients with access to improved treatments may help them to survive longer and improve their quality of life. PHM’s research has been published in the peer-reviewed publication “Frontiers in Oncology.” In this case report, we summarize the treatment course for a 73-year-old male patient, who came to PHM for assistance in managing his mCRPC. Read More
Ask Our Experts April 27, 2023 What to Know About a “Breakthrough” Weight Loss Drugs The drugs, Wegovy® and Ozempic® have been in the news and trending on social media due to their unprecedented success in helping people lose large amounts of weight. Our experts at PHM answer some common questions about the recently FDA approved drug, Wegovy. Read More
